Physiological cellular reprogramming and cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Seminars in Cancer Biology

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.semcancer.2010.02.002PMID 20188173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Sox17 promotes differentiation in mouse embryonic stem cells by directly regulating extraembryonic gene expression and indirectly antagonizing self-renewal.

  2010cited by this paper
• Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model

  2010cited by this paper
• Direct conversion of fibroblasts to functional neurons by defined factors

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• Stem cells: The promises and perils of p53

  2009cited by this paper
• Epigenetic reprogramming and induced pluripotency

  2009cited by this paper
• Stem-cell driven cancer: "Hands-off" regulation of cancer development

  2009cited by this paper
• Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.

  2009influential reference
• Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation.

  2009cited by this paper
• Regulated Fluctuations in Nanog Expression Mediate Cell Fate Decisions in Embryonic Stem Cells

  2009cited by this paper
• Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

  2009cited by this paper
• Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells.

  2009cited by this paper
• Reprogramming cell fates: reconciling rarity with robustness

  2009cited by this paper
• MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.

  2009cited by this paper
• Senescence impairs successful reprogramming to pluripotent stem cells.

  2009cited by this paper
• Models of haematopoiesis: seeing the wood for the trees

  2009cited by this paper
• B‐cell acute lymphoblastic leukaemia: towards understanding its cellular origin

  2009cited by this paper
• Elite and stochastic models for induced pluripotent stem cell generation

  2009influential reference
• Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.

  2009cited by this paper
• A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

  2009cited by this paper
• Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes.

  2009cited by this paper
• Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

  2009cited by this paper
• The Ink4/Arf locus is a barrier for iPS cell reprogramming

  2009cited by this paper
• PML–RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors

  2009cited by this paper
• Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.

  2009cited by this paper
• The role of cellular plasticity in cancer development.

  2009cited by this paper
• Histone deacetylase inhibitors in cancer therapy.

  2009cited by this paper
• Forcing cells to change lineages

  2009cited by this paper
• Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors

  2009cited by this paper
• Linking the p53 tumor suppressor pathway to somatic cell reprogramming

  2009cited by this paper
• Oct4-induced pluripotency in adult neural stem cells.

  2009cited by this paper
• Crypt stem cells as the cells-of-origin of intestinal cancer

  2009cited by this paper
• Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective.

  2009influential reference
• Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells

  2009cited by this paper
• Stem cell states, fates, and the rules of attraction.

  2009cited by this paper
• Role of the murine reprogramming factors in the induction of pluripotency.

  2009influential reference
• Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia

  2008influential reference
• Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.

  2008cited by this paper
• In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.

  2008cited by this paper
• Efficient tumor formation by single human melanoma cells

  2008cited by this paper
• Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

  2008cited by this paper
• A combined chemical and genetic approach for the generation of induced pluripotent stem cells.

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• Cancer induction by restriction of oncogene expression to the stem cell compartment

  2008cited by this paper
• Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states.

  2008cited by this paper
• Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

  2008cited by this paper
• Nuclear Reprogramming in Cells

  2008cited by this paper
• Transcriptome-wide noise controls lineage choice in mammalian progenitor cells

  2008influential reference
• Module map of stem cell genes guides creation of epithelial cancer stem cells.

  2008influential reference
• Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

  2008influential reference
• Cancer's source in the peripheral nervous system

  2008cited by this paper
• De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes

  2008cited by this paper
• The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.

  2008cited by this paper
• Two supporting factors greatly improve the efficiency of human iPSC generation.

  2008cited by this paper
• Efficient tumour formation by single human melanoma cells

  2008cited by this paper
• In vivo reprogramming of adult pancreatic exocrine cells to β-cells

  2008cited by this paper
• c-Myc is dispensable for direct reprogramming of mouse fibroblasts.

  2008cited by this paper
• Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

  2008influential reference
• The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer*

  2008cited by this paper
• Initiating and Cancer-Propagating Cells in TEL-AML1-Associated Childhood Leukemia

  2008cited by this paper
• Faculty Opinions recommendation of In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

  2008cited by this paper
• Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder.

  2007cited by this paper
• The theoretical basis of cancer‐stem‐cell‐based therapeutics of cancer: can it be put into practice?

  2007cited by this paper
• Epigenetics: Reversing the 'irreversible'

  2007cited by this paper
• Chronic myeloid leukaemia as a model of disease evolution in human cancer

  2007cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Pax5: the guardian of B cell identity and function

  2007influential reference
• Modeling the Initiation and Progression of Human Acute Leukemia in Mice

  2007cited by this paper
• Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors

  2007cited by this paper
• Cancer epigenomics: DNA methylomes and histone-modification maps

  2007cited by this paper
• The sequential determination model of hematopoiesis.

  2007cited by this paper
• The field of cancer research: an indicator of present transformations in biology

  2007cited by this paper
• Transcriptional networks regulating hematopoietic cell fate decisions

  2007cited by this paper
• Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

  2006influential reference
• Histone Deacetylase Inhibitors for Cancer Therapy

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

  2006cited by this paper
• G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis

  2006cited by this paper
• Determinants of lymphoid-myeloid lineage diversification.

  2006cited by this paper
• Nuclear reprogramming and pluripotency

  2006cited by this paper
• Chromatin remodeling, cancer and chemotherapy.

  2006cited by this paper
• Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.

  2006influential reference
• Primitive, Quiescent and Difficult to Kill: The Role of Non-Proliferating Stem Cells in Chronic Myeloid Leukemia

  2006cited by this paper
• From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research

  2006cited by this paper
• The cancer epigenome--components and functional correlates.

  2006cited by this paper
• Precancerous Stem Cells Have the Potential for both Benign and Malignant Differentiation

  2006influential reference
• The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells

  2006cited by this paper
• Genetic regulatory networks programming hematopoietic stem cells and erythroid lineage specification.

  2006cited by this paper
• Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes

  2005cited by this paper
• The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

  2005cited by this paper
• Core transcriptional regulatory circuitry in human embryonic stem cells.

  2005cited by this paper
• Reprogramming of a melanoma genome by nuclear transplantation.

  2004cited by this paper
• MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

  2004cited by this paper
• Stepwise reprogramming of B cells into macrophages.

  2004influential reference
• Nuclear cloning of embryonal carcinoma cells.

  2004cited by this paper
• MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

  2003cited by this paper

• A systems pharmacology approach for targeted study of potential inflammatory pathways and their genes in atherosclerosis

  2024cites this paper
• Dedifferentiation and in vivo reprogramming of committed cells in wound repair

  2022cites this paper
• Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases.

  2020cites this paper
• Cancer Stem Cells in Oral Carcinoma

  2020cites this paper
• Chapter 2 Cancer Stem Cells — Biopathology with Reference to Head and Neck Cancers

  2019cites this paper
• Head and neck cancer management and cancer stem cells implication

  2019cites this paper
• Active Fraction from Embryo Fish Extracts Induces Reversion of the Malignant Invasive Phenotype in Breast Cancer through Down-Regulation of TCTP and Modulation of E-cadherin/β-catenin Pathway

  2019cites this paper
• Stem Cells and Cancer

  2018cites this paper
• In vivo somatic cell reprogramming for tissue regeneration: the emerging role of the local microenvironment.

  2018cites this paper
• Cancer Stem Cells—Biopathology with Reference to Head and Neck Cancers

  2017cites this paper
• Autophagy in stem and progenitor cells

  2016cites this paper
• Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style

  2016cites this paper
• Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.

  2015cites this paper
• Autophagy and cell reprogramming

  2015cites this paper
• Bioenergetics mechanism and autophagy in breast cancer stem cells

  2015cites this paper
• The unforeseen challenge: from genotype-to-phenotype in cell populations

  2015cites this paper
• Xenopatients 2.0: Reprogramming the epigenetic landscapes of patient-derived cancer genomes

  2014cites this paper
• A systemic approach to cancer treatment: tumor cell reprogramming focused on endocrine-related cancers.

  2014cites this paper
• Genetically engineered mouse models of human B-cell precursor leukemias

  2014cites this paper
• Reprogramming the epigenetic landscapes of patient-derived cancer genomes

  2014cites this paper
• The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells

  2013cites this paper
• Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway

  2013cites this paper
• Basal/HER2 breast carcinomas

  2013cites this paper
• The cancer stem cell hypothesis applied to oral carcinoma.

  2013cites this paper
• Cell hierarchy, metabolic flexibility and systems approaches to cancer treatment.

  2013cites this paper
• An investigation into the chromatin structure ofhuman telomeres

  2013cites this paper
• Current concepts of how to eliminate cancer stem cells

  2013cites this paper
• Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells

  2013cites this paper
• Autophagy in stem cells

  2013cites this paper
• The elite and stochastic model for iPS cell generation: Multilineage‐differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells

  2013cites this paper
• Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB

  2012cites this paper
• A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors

  2012cites this paper
• Muse cells and induced pluripotent stem cell: implication of the elite model

  2012cites this paper
• Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer

  2011cites this paper
• Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts

  2011cites this paper
• Suv4-20h Abrogation Enhances Telomere Elongation during Reprogramming and Confers a Higher Tumorigenic Potential to iPS Cells

  2011cites this paper
• An Overview of Cancer Chemopreventive Potential and Safety of Proanthocyanidins

  2011cites this paper
• Acute lymphoblastic leukemia and developmental biology

  2011cites this paper
• Getting to the stem of cancer.

  2010cites this paper